Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06809933 · ClinicalTrials.gov registry record · NA
Exercise and Movement to Enhance Resiliency in Cancer Patients
A NA study of Gynecologic Cancer, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06809933: Recruiting NA study of Gynecologic Cancer, sponsored by University of California, San Francisco.
NCT06809933 is a NA study of Gynecologic Cancer that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 763-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06809933, a NA study of Gynecologic Cancer, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.
Primary Outcome
Feasibility of the intervention is defined as \>= 30% recruitment rate for participants in Stage 1.
Conditions Studied
Interventions
- OTHER Digital Health Mobile App
- OTHER Virtual Support Group
- OTHER Health Coaching
- OTHER FitBit
- OTHER Handouts
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2031-08-31 |
| Phase | NA |
What NCT06809933 shows while recruiting
NCT06809933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 763-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Gynecologic Cancer appearing as the primary indexed condition, and to 5 interventions - of which Digital Health Mobile App is the first listed.
NCT06809933 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06809933 about?
NCT06809933 is a clinical study titled "Exercise and Movement to Enhance Resiliency in Cancer Patients". This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatm...
What is the current status of trial NCT06809933?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-24. Estimated completion is 2031-08-31.
What conditions does trial NCT06809933 study?
This clinical trial studies the following conditions: Gynecologic Cancer.
What interventions are being tested in trial NCT06809933?
The interventions under investigation include: Digital Health Mobile App (OTHER), Virtual Support Group (OTHER), Health Coaching (OTHER), FitBit (OTHER), Handouts (OTHER).
Who is sponsoring clinical trial NCT06809933?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06809933 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06809933's enrollment target sits among peer trials
60 28th of 55 higher than 27 of 55 other Gynecologic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI